de Almeida C, Furin J, Sumiya A, Silva D, Mitnick C
Front Public Health. 2025; 12():1431881.
PMID: 39776473
PMC: 11703962.
DOI: 10.3389/fpubh.2024.1431881.
Chin K, Anibarro L, Chang Z, Palasuberniam P, Mustapha Z, Sarmiento M
Curr Res Microb Sci. 2024; 7:100295.
PMID: 39512261
PMC: 11541417.
DOI: 10.1016/j.crmicr.2024.100295.
Soeroso N, Siahaan L, Khairunnisa S, Anggriani R, Aida A, Eyanoer P
J Fungi (Basel). 2024; 10(8).
PMID: 39194855
PMC: 11355089.
DOI: 10.3390/jof10080529.
Gonzalez-Gonzalez A, Sanchez-Sanchez O, Wan B, Franzblau S, Palos I, Espinoza-Hicks J
RSC Med Chem. 2024; 15(8):2785-2791.
PMID: 39149106
PMC: 11324059.
DOI: 10.1039/d4md00221k.
Guy C, Gott J, Ramirez-Cardenas J, de Wolf C, Furze C, West G
Chem Sci. 2024; .
PMID: 39144457
PMC: 11317875.
DOI: 10.1039/d4sc00721b.
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Infection.
Weng S, Li Q, Zhang T, Lin T, He Y, Yang G
Vaccines (Basel). 2024; 12(6).
PMID: 38932351
PMC: 11209282.
DOI: 10.3390/vaccines12060622.
Polypharmacology-Driven Discovery and Design of Highly Selective, Dual and Multitargeting Inhibitors of - A Review.
Amandy F, Neri G, Manzano J, Go A, Macabeo A
Curr Drug Targets. 2024; 25(9):620-634.
PMID: 38859782
DOI: 10.2174/0113894501306302240526160804.
A case report of using gauze packing to treat postoperative chest bleeding after left pneumonectomy for secondary rifampicin-resistant tuberculosis.
Liu Q, Zhou X, Yao L, Xu F, Tang P, Li T
IDCases. 2024; 36:e01953.
PMID: 38707650
PMC: 11067492.
DOI: 10.1016/j.idcr.2024.e01953.
Global respiratory health priorities at the beginning of the 21st century.
M Greene C, Abdulkadir M
Eur Respir Rev. 2024; 33(172).
PMID: 38599674
PMC: 11004770.
DOI: 10.1183/16000617.0205-2023.
Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran: Systematic review and meta-analysis.
Abbasian S, Heidari H, Tadi D, Kardan-Yamchi J, Taji A, Darbandi A
J Clin Tuberc Other Mycobact Dis. 2024; 35:100430.
PMID: 38560029
PMC: 10981085.
DOI: 10.1016/j.jctube.2024.100430.
Determinants of drug-resistant tuberculosis in Hunan province, China: a case-control study.
Akalu T, Clements A, Xu Z, Bai L, Alene K
BMC Infect Dis. 2024; 24(1):198.
PMID: 38350860
PMC: 10863170.
DOI: 10.1186/s12879-024-09106-5.
The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis.
Zhou M, Liu A, Yang X, Guan C, Zhang Y, Wang M
Front Pharmacol. 2024; 14:1331371.
PMID: 38259285
PMC: 10800833.
DOI: 10.3389/fphar.2023.1331371.
Structural Insights into the Penicillin-Binding Protein 4 (DacB) from .
Kang S, Kim D
Int J Mol Sci. 2024; 25(2).
PMID: 38256057
PMC: 10815838.
DOI: 10.3390/ijms25020983.
Trends and Progress on Antibiotic-Resistant and Genes in relation to Human Immunodeficiency Virus.
Mbewana Ntshanka N, Msagati T
Can J Infect Dis Med Microbiol. 2023; 2023:6659212.
PMID: 38077655
PMC: 10703531.
DOI: 10.1155/2023/6659212.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Gupta-Wright A, den Boon S, MacLean E, Cirillo D, Cobelens F, Gillespie S
Bull World Health Organ. 2023; 101(11):730-737.
PMID: 37961060
PMC: 10630735.
DOI: 10.2471/BLT.23.290901.
Computed Tomography Manifestations in Patients with Rifampin Primary Drug-Resistant Tuberculosis in an Infectious Disease Hospital in the Yi Autonomous Prefecture, China.
Wang T, Yang Q, Gao Y, Zhang R, Zhou C, Kong W
Int J Gen Med. 2023; 16:5109-5118.
PMID: 37954652
PMC: 10637220.
DOI: 10.2147/IJGM.S428962.
Current and Future Technologies for the Detection of Antibiotic-Resistant Bacteria.
Yamin D, Uskokovic V, Wakil A, Goni M, Shamsuddin S, Mustafa F
Diagnostics (Basel). 2023; 13(20).
PMID: 37892067
PMC: 10606640.
DOI: 10.3390/diagnostics13203246.
: Pathogenesis and therapeutic targets.
Yang J, Zhang L, Qiao W, Luo Y
MedComm (2020). 2023; 4(5):e353.
PMID: 37674971
PMC: 10477518.
DOI: 10.1002/mco2.353.
Antibiotic Resistance and Its Impact on Disease Management.
Nadgir C, Biswas D
Cureus. 2023; 15(4):e38251.
PMID: 37261148
PMC: 10226836.
DOI: 10.7759/cureus.38251.
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in Mycobacteria.
Malwal S, Mazurek B, Ko J, Xie P, Barnes C, Varvitsiotis C
J Med Chem. 2023; 66(11):7553-7569.
PMID: 37235809
PMC: 10330530.
DOI: 10.1021/acs.jmedchem.3c00398.